Chemical Name: | Butanediamide,N4-hydroxy-N1-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)-, (2R)- |
CAS Number: | 142880-36-2 |
Product Number: | AG00350G(AGN-PC-0PT4CR) |
Synonyms: | |
MDL No: | |
Molecular Formula: | C20H28N4O4 |
Molecular Weight: | 388.4607 |
Illomastat, also known as GM6001, is a potent inhibitor of matrix metalloproteinases (MMPs). MMPs are a group of enzymes that play a crucial role in tissue remodeling, wound healing, and various pathological processes such as cancer metastasis and inflammation. Illomastat has been widely used in chemical synthesis as a tool compound to study the role of MMPs in various biological processes.In chemical synthesis, Illomastat is used to inhibit the activity of MMPs present in biological samples or cell cultures. By inhibiting MMPs, Illomastat can help researchers understand the specific roles of these enzymes in disease progression and normal physiological processes. This inhibition can also lead to the discovery of new drug targets for conditions such as cancer and inflammatory diseases.Additionally, Illomastat's ability to inhibit MMPs has been utilized in the development of novel therapeutic agents. By studying the effects of Illomastat on MMP activity, researchers can identify potential drug candidates that target specific MMPs involved in disease pathways. Overall, Illomastat plays a crucial role in advancing our knowledge of MMP biology and its implications for drug discovery and development.